Asana, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 23, 2025, discloses a significant change in executive leadership for Asana, Inc. The report details the appointment of a new Chief Executive Officer (CEO) and the retirement of the current CEO, effective July 21, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and governance changes.
Material Changes
- Leadership Transition: Daniel Rogers is appointed as CEO and a Class III director, effective July 21, 2025. Dustin Moskovitz, current President and CEO, will retire from those roles on the same date to become a non-employee director and Chair of the Board.
- Board Expansion: The Board size has been increased to ten members to accommodate Mr. Rogers.
- Compensation Structure: Mr. Rogers' total compensation package includes:
- Annual Base Salary: $650,000.
- Target Annual Bonus: $650,000 (guaranteed for fiscal 2026, prorated).
- Restricted Stock Units (RSUs): Grant date value of $18,200,000, vesting over three years.
- Performance-Based RSUs (PSUs): Target grant date value of $16,800,000, with a maximum potential vesting of 200% based on revenue growth and relative total shareholder return (rTSR).
Outlook, Risks, and Contingencies
The filing outlines specific severance and acceleration provisions contingent on termination scenarios:
- Termination Without Cause (Outside Change in Control): Entitles Mr. Rogers to one year of base salary, pro-rated bonus, 12 months of health insurance, and pro-rated accelerated vesting of RSUs. PSUs are forfeited.
- Termination Without Cause or Good Reason (Within Change in Control): Entitles Mr. Rogers to 1.5x the sum of base salary and target bonus, 18 months of health insurance, full accelerated vesting of RSUs, and full acceleration of PSUs (at greater of actual or target performance).
- Death or Disability: Triggers immediate 100% vesting of unvested RSUs and 12 months of continued health coverage.
Investor Verification Checklist
- Verify the exact vesting commencement date (VCD) for the RSUs as approved by the Board.
- Confirm the specific performance metrics and peer group used for the relative total shareholder return (rTSR) calculation in the PSU grant.
- Review the full text of the Offer Letter (Exhibit 10.1) for detailed terms regarding the "good reason" definition and change in control provisions.
- Monitor the transition plan between Mr. Moskovitz and Mr. Rogers to ensure operational continuity.